Brembate, Italy

Raffaella Cincinelli

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Raffaella Cincinelli: Innovating Cancer Treatment Through Retinoid Derivatives**

Introduction

Raffaella Cincinelli, an esteemed inventor based in Brembate, Italy, has made significant contributions to medical science, particularly in the field of oncology. With a total of three patents to his name, Cincinelli's innovative work focuses on the development of retinoid derivatives with antitumor activity.

Latest Patents

Among his latest patents, one notable invention is centered on retinoid derivatives that show promising antitumor properties. This invention relates to compounds of a specific formula and includes pharmaceutical compositions aimed at treating cancer and other diseases associated with altered angiogenesis. These diseases comprise arthritic pathologies, diabetic retinopathy, psoriasis, and chronic inflammatory diseases, showcasing the broader therapeutic potential of his discoveries.

Career Highlights

Cincinelli's career is marked by his dedication to research and innovation. His work with retinoid derivatives exemplifies his commitment to exploring novel treatment avenues for complex medical conditions. Through rigorous research and development, he aims to provide effective solutions that could enhance patient outcomes in oncology and beyond.

Collaborations

Cincinelli collaborates closely with notable colleagues, including Claudio Pisano and Sabrina Dallavalle. These partnerships underscore the collaborative nature of scientific research, as they collectively strive to advance their fields with innovative solutions.

Conclusion

Raffaella Cincinelli stands out as a visionary inventor, utilizing his expertise to tackle significant health challenges. His groundbreaking work on retinoid derivatives not only reflects his innovative spirit but also holds the potential to transform treatment paradigms in cancer and other angiogenesis-related diseases. As he continues his work with Biogem S.c. a R.l., the scientific community anticipates further advancements stemming from his research and collaborations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…